Sponsor Dossier
Alembic Pharmaceuticals
Sponsor Dossier for Alembic Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALEMBIC
- Brand: ALEMVIR
- Brand: ALEXIBIC
- Brand: APIBIC
- Brand: APIXABAN
- Brand: APIXIBIC
- Brand: APO-MACITENTAN
- Brand: ARIVEL
About
Alembic Pharmaceuticals is an Australian Private Company with ABN 86161533133, registered in Victoria. The entity is active and registered for GST.
Portfolio
Alembic Pharmaceuticals has 34 brands on the ARTG, of which 1 is indexable and 0 carry a Product Information document. 1 brand is PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ALEMBIC, ALEMVIR, ALEXIBIC, APIBIC, APIXABAN, APIXIBIC, APO-MACITENTAN, ARIVEL, ARX-MACITENTAN, AXIBIC, CANDELEM, CANDESARTAN HCTZ AGH.
Therapeutic focus
— Cardiology: 21 brands — Psychiatry: 7 brands — Neurology: 3 brands — Infectious Disease: 2 brands — Haematology: 1 brand
PBS footprint
1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.